Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0.01% · short 0.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for LianBio only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
LianBio, operates as a biotechnology company in China and other Asian countries. It offers medicines for cardiovascular, oncology, ophthalmology, and inflammatory disease indications. The company develops mavacamten for the treatment of obstructive hypertrophic cardiomyopathy, which is in Phase 3 EXPLORER-CN trial; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease, which is in Phase 3 LIBRA trial; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of FGFR2 gene amplification; and BBP-398 for solid tumors. The company was formerly known as LianBio and changed its name to LianMedical in July 2026. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
9 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Other |
| $5.7K |
| SEC |
| Poukalov Konstantin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| GIANAKAKOS ANASTASIOS | Other | $91.5K | SEC |
| Stone Adam Leo | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Silbermann Susan Michele | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Silbermann Susan Michele | Other | $91.5K | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | Other | $91.5K | SEC |
| Stone Adam Leo | Exercise | $91.5K | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | Exercise | $91.5K | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | Exercise | $91.5K | SEC |
| GIANAKAKOS ANASTASIOS | Exercise | $91.5K | SEC |
| Poukalov Konstantin | Exercise | $91.5K | SEC |
| GIANAKAKOS ANASTASIOS | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDtrack record | Other | $91.5K | SEC |
| Poukalov Konstantin | Other | $91.5K | SEC |
| Stone Adam Leo | Other | $91.5K | SEC |
| Silbermann Susan Michele | Exercise | $91.5K | SEC |
| Poukalov Konstantin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stone Adam Leo | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chen Wei Wei | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| GIANAKAKOS ANASTASIOS | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PERCEPTIVE ADVISORS LLCtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |